Author: Ashraf, Mohammad Ali; Sherafat, Alireza; Pourdast, Alieh; Nazemi, Pershang; Mohraz, Minoo
Title: The application of direct viral cytopathic hypothesis to design drug trials in the battle against COVID-19 Cord-id: mjd5agvf Document date: 2020_8_15
ID: mjd5agvf
Snippet: COVID-19 has caused many deaths worldwide. Systemic complications alongside coagulopathy, and ARDS account for the majority of COVID-19 mortalities. The pathogenesis of the disease can be explained by two theories of direct viral cytopathy and systemic inflammatory cascade of events. ACE-2 is shown to be the cellular host receptor for SARS-CoV-2. It might be the key to explain the pathogenesis of systemic complications with a focus on the direct viral cytopathic hypothesis. Different medications
Document: COVID-19 has caused many deaths worldwide. Systemic complications alongside coagulopathy, and ARDS account for the majority of COVID-19 mortalities. The pathogenesis of the disease can be explained by two theories of direct viral cytopathy and systemic inflammatory cascade of events. ACE-2 is shown to be the cellular host receptor for SARS-CoV-2. It might be the key to explain the pathogenesis of systemic complications with a focus on the direct viral cytopathic hypothesis. Different medications tend to show up in many in vitro drug screens. However, more trials are needed to translate their application into in vivo efficacy.
Search related documents:
Co phrase search for related documents- acute cardiac injury and lymphocytopenia acute cardiac injury: 1, 2
- acute kidney injury and liver biopsy: 1, 2, 3
- acute kidney injury and lymphocytopenia acute cardiac injury: 1
- acute respiratory syndrome and liver biopsy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory syndrome and lysosomotropic agent: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date